Literature DB >> 20492535

Experimental systemic virulence of oral Candida dubliniensis isolates in comparison with Candida albicans, Candida tropicalis and Candida krusei.

Cristiane Yumi Koga-Ito1, Edson Yukio Komiyama, Clélia Aparecida de Paiva Martins, Thássia Castro Vasconcellos, Antonio Olavo Cardoso Jorge, Yasmin Rodarte Carvalho, Renata Falchete do Prado, Ivan Balducci.   

Abstract

There are no previous studies on the comparative virulence of Candida dubliniensis with other non-albicans species. The aim of this study was to compare the virulence and infection kinetics of C. dubliniensis and other species. Candida albicans, C. dubliniensis, Candida tropicalis and Candida krusei (reference strains) were inoculated intravenously in mice. For infection kinetics evaluation, a group of five animals were sacrificed after 6 h, 3, 7, 14 and 21 days. Microbiological evaluations (liver, spleen, kidneys, lungs and brain) and histopathological examination of the kidney were performed. The results of virulence evaluation were analysed using Kaplan-Meier survival analysis (5%). Candida dubliniensis-inoculated mice survived for longer periods compared with those with C. albicans (P = 0.005). No differences were detected in relation to C. tropicalis (P = 0.326) and C. krusei (P = 0.317). Most of the organs were persistently colonised by C. albicans and C. dubliniensis even by day 21. Tendency of C. krusei clearance was observed in all organs. Fungal masses and renal lesions were observed after inoculation of C. albicans, C. dubliniensis and C. tropicalis. Within the limits of the study, data on survival rate and dissemination capacity suggest that C. dubliniensis is less virulent than C. albicans.
© 2010 Blackwell Verlag GmbH.

Entities:  

Mesh:

Year:  2010        PMID: 20492535     DOI: 10.1111/j.1439-0507.2010.01899.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  8 in total

1.  Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus.

Authors:  Evelyn E Nash; Brian M Peters; Paul L Fidel; Mairi C Noverr
Journal:  Infect Immun       Date:  2015-10-19       Impact factor: 3.441

2.  Usefulness of the Non-conventional Caenorhabditis elegans Model to Assess Candida Virulence.

Authors:  Marcelo Ortega-Riveros; Iker De-la-Pinta; Cristina Marcos-Arias; Guillermo Ezpeleta; Guillermo Quindós; Elena Eraso
Journal:  Mycopathologia       Date:  2017-05-18       Impact factor: 2.574

3.  Candida albicans versus Candida dubliniensis: Why Is C. albicans More Pathogenic?

Authors:  Gary P Moran; David C Coleman; Derek J Sullivan
Journal:  Int J Microbiol       Date:  2011-09-04

4.  Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates.

Authors:  Juliana C Junqueira; Beth B Fuchs; Maged Muhammed; Jeffrey J Coleman; Jamal M A H Suleiman; Simone F G Vilela; Anna C B P Costa; Vanessa M C Rasteiro; Antonio O C Jorge; Eleftherios Mylonakis
Journal:  BMC Microbiol       Date:  2011-11-04       Impact factor: 3.605

5.  Hosting infection: experimental models to assay Candida virulence.

Authors:  Donna M Maccallum
Journal:  Int J Microbiol       Date:  2011-12-22

6.  Csr1/Zap1 Maintains Zinc Homeostasis and Influences Virulence in Candida dubliniensis but Is Not Coupled to Morphogenesis.

Authors:  Bettina Böttcher; Katja Palige; Ilse D Jacobsen; Bernhard Hube; Sascha Brunke
Journal:  Eukaryot Cell       Date:  2015-05-22

Review 7.  An Update on Candida tropicalis Based on Basic and Clinical Approaches.

Authors:  Diana L Zuza-Alves; Walicyranison P Silva-Rocha; Guilherme M Chaves
Journal:  Front Microbiol       Date:  2017-10-13       Impact factor: 5.640

Review 8.  Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen.

Authors:  Manuela Gómez-Gaviria; Héctor M Mora-Montes
Journal:  Infect Drug Resist       Date:  2020-06-10       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.